Comparison of induction of abortion in both inpatients and outpatients in the first trimester of pregnancy

Comparison of successes and complications of inpatient and outpatient treatment in the first trimester abortion with misoprostol

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190128042522N1

Enrollment

222

Registered

2020-05-09

Start date

2019-02-20

Completion date

Unknown

Last updated

2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Induction of abortion in the first trimester as an outpatient with misoprostol. Missed abortion

Interventions

Intervention 1: Intervention group: In the first group (inpatients), 800 micrograms of vaginal misoprostol are given every 24 hours to 2 doses. In the event of fever (T=38 ° C), a prescription for ace

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Pregnant women with gestational age less than 14 weeks based on ultrasonography and the last menstrual period Stable hemodynamic conditions Patients living with family Possibility to move quickly to the hospital

Exclusion criteria

Exclusion criteria: The presence of cardiac, pulmonary, hepatic and uncontrolled sizure disorders IUD in the uterus Hemoglobin less than 10 Coagulopathy state or severe bleeding The presence of fever or signs of infectious abortion Sensitivity to misoprostol

Design outcomes

Primary

Measure	Time frame
Success of spontaneous abortion. Timepoint: After intervention up to 1 weeks. Method of measurement: Questionnaire and ultrasound to evaluation of fetal and placental abortion.	—

Secondary

Measure	Time frame
Patient satisfaction. Timepoint: after intervention up to 1 weeks. Method of measurement: check-list (Outcome of treatment, Physical and mental satisfaction, Costs spent).;The success rate of treatment without any other medical intervention. Timepoint: after intervention up to 1 weeks. Method of measurement: check-list (outcome of treatment, rang of hemoglobin).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactArezou Sedaghati

Mashhad University of Medical Sciences

sedaghatia951@mums.ac.ir+98 51 3608 0015

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026